Cyclopharm Ltd. | Income Statement
Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
11,882.10
12,046.80
12,582.50
14,385.50
13,188.80
13,404.20
Cost of Goods Sold (COGS) incl. D&A
7,891.00
7,106.70
6,120.90
7,239.10
6,835.90
7,759.60
Gross Income
3,991.10
4,940.10
6,461.60
7,146.40
6,352.90
5,644.70
SG&A Expense
4,079.50
3,932.80
3,884.60
5,123.50
7,701.40
8,184.30
EBIT
559.60
605.30
2,577.00
-
1,348.60
2,539.60
Unusual Expense
8,860.20
2,650.00
2,104.70
-
29.60
309
Non Operating Income/Expense
141.00
241.70
612.10
630.90
366.70
149.40
Interest Expense
270.30
107.30
25.40
18.00
20.10
26.10
Pretax Income
9,533.50
3,410.30
4,090.30
1,421.30
1,685.40
2,003.90
Income Tax
146.10
595.30
702.70
530.00
160.90
1,968.50
Equity in Affiliates
252.60
60.00
-
-
-
-
Consolidated Net Income
9,640.10
4,065.60
4,793.00
891.40
1,524.60
35.50
Net Income
9,640.10
4,065.60
4,793.00
891.40
1,524.60
35.50
Net Income After Extraordinaries
9,640.10
4,065.60
4,793.00
891.40
1,524.60
35.50
Net Income Available to Common
9,640.10
4,065.60
4,793.00
891.40
1,524.60
35.50
EPS (Basic)
0.17
0.07
0.09
0.02
0.02
-
Basic Shares Outstanding
58,140.00
58,365.70
56,201.00
57,903.10
67,891.30
67,973.90
EPS (Diluted)
0.17
0.07
0.08
0.02
0.02
-
Diluted Shares Outstanding
58,140.00
58,365.70
57,903.10
57,903.10
67,891.30
67,973.90
EBITDA
83.50
871.30
2,721.20
2,129.30
1,030.50
2,029.40
Other Operating Expense
471.20
402.00
-
-
-
-
Non-Operating Interest Income
15.40
20.50
46.20
47.30
79.50
103.40
About Cyclopharm
View Profile
